- Rocket Pharmaceuticals (NASDAQ:RCKT) will host a conference call on November 26th, at 8:30 a.m. ET to reveal their first adeno-associated viral vector (AAV) gene therapy program.
Rocket Pharmaceuticals to reveal first AAV gene therapy program on November 26
Recommended For You
More Trending News
About RCKT Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
RCKT | - | - |
Rocket Pharmaceuticals, Inc. |